Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
企業コードCOSM
会社名Cosmos Health Inc
上場日May 19, 2010
最高経営責任者「CEO」Siokas (Grigorios)
従業員数149
証券種類Ordinary Share
決算期末May 19
本社所在地5 Agiou Georgiou, Pilea
都市THESSALONIKI
証券取引所NASDAQ OMX - NASDAQ BASIC
国Greece
郵便番号554 38
電話番号303125363102
ウェブサイトhttps://www.cosmosholdingsinc.com/
企業コードCOSM
上場日May 19, 2010
最高経営責任者「CEO」Siokas (Grigorios)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし